|
1
|
Danaei G, Finucane MM, Lu Y, Singh GM,
Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA,
et al: National, regional, and global trends in fasting plasma
glucose and diabetes prevalence since 1980: Systematic analysis of
health examination surveys and epidemiological studies with 370
country-years and 2.7 million participants. Lancet. 378:31–40.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Meshkani R and Adeli K: Hepatic insulin
resistance, metabolic syndrome and cardiovascular disease. Clin
Biochem. 42:1331–1346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Muller D, Huang GC, Amiel S, Jones PM and
Persaud SJ: Gene expression heterogeneity in human islet endocrine
cells in vitro: The insulin signalling cascade. Diabetologia.
50:1239–1242. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dominguez V, Raimondi C, Somanath S,
Bugliani M, Loder MK, Edling CE, Divecha N, da Silva-Xavier G,
Marselli L, Persaud SJ, et al: Class II phosphoinositide 3-kinase
regulates exocytosis of insulin granules in pancreatic beta cells.
J Biol Chem. 286:4216–4225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kolic J, Manning Fox JE, Chepurny OG,
Spigelman AF, Ferdaoussi M, Schwede F, Holz GG and MacDonald PE:
PI3 kinases p110α and PI3K-C2β negatively regulate cAMP via PDE3/8
to control insulin secretion in mouse and human islets. Mol Metab.
5:459–471. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kolic J, Spigelman AF, Plummer G, Leung E,
Hajmrle C, Kin T, Shapiro AM, Manning Fox JE and MacDonald PE:
Distinct and opposing roles for the phosphatidylinositol 3-OH
kinase catalytic subunits p110α and p110β in the regulation of
insulin secretion from rodent and human beta cells. Diabetologia.
56:1339–1349. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aoyagi K, Ohara-Imaizumi M, Nishiwaki C,
Nakamichi Y, Ueki K, Kadowaki T and Nagamatsu S: Acute inhibition
of PI3K-PDK1-Akt pathway potentiates insulin secretion through
upregulation of newcomer granule fusions in pancreatic β-cells.
PLoS One. 7:e473812012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Herranz H and Cohen SM: MicroRNAs and gene
regulatory networks: Managing the impact of noise in biological
systems. Genes Dev. 24:1339–1344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lytle JR, Yario TA and Steitz JA: Target
mRNAs are repressed as efficiently by microRNA-binding sites in the
5′ UTR as in the 3′ UTR. Proc Natl Acad Sci USA. 104:pp. 9667–9672.
2007; View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arunachalam G, Lakshmanan AP, Samuel SM,
Triggle CR and Ding H: Molecular interplay between microRNA-34a and
sirtuin1 in hyperglycemia-mediated impaired angiogenesis in
endothelial cells: Effects of metformin. J Pharmacol Exp Ther.
356:314–323. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima
S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P
and Stoffel M: A pancreatic islet-specific microRNA regulates
insulin secretion. Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang S, Wang L, Dou L, Guo J, Fang W, Li
M, Meng X, Man Y, Shen T, Huang X and Li J: MicroRNA 152 regulates
hepatic glycogenesis by targeting PTEN. FEBS J. 283:1935–1946.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
National Research Council (US) Institute
for Laboratory Animal Research, . The Development of Science-based
Guidelines for Laboratory Animal Care: Proceedings of the November
2003 International Workshop. Washington (DC). National Academies
Press (US); 2004;
|
|
14
|
Lau T, Carlsson PO and Leung PS: Evidence
for a local angiotensin-generating system and dose-dependent
inhibition of glucose-stimulated insulin release by angiotensin II
in isolated pancreatic islets. Diabetologia. 47:240–248. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Leclercq IA, Da Silva Morais A, Schroyen
B, Van Hul N and Geerts A: Insulin resistance in hepatocytes and
sinusoidal liver cells: Mechanisms and consequences. J Hepatol.
47:142–156. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Joglekar MV, Parekh VS and Hardikar AA:
Islet-specific microRNAs in pancreas development, regeneration and
diabetes. Indian J Exp Biol. 49:401–408. 2011.PubMed/NCBI
|
|
18
|
Mao Y, Mohan R, Zhang S and Tang X:
MicroRNAs as pharmacological targets in diabetes. Pharmacol Res.
75:37–47. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Plaisance V, Abderrahmani A, Perret-Menoud
V, Jacquemin P, Lemaigre F and Regazzi R: MicroRNA-9 controls the
expression of Granuphilin/Slp4 and the secretory response of
insulin-producing cells. J Biol Chem. 281:26932–26942. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liang J, Liu C, Qiao A, Cui Y, Zhang H,
Cui A, Zhang S, Yang Y, Xiao X, Chen Y, et al: MicroRNA-29a-c
decrease fasting blood glucose levels by negatively regulating
hepatic gluconeogenesis. J Hepatol. 58:535–542. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dou L, Wang S, Sui X, Meng X, Shen T,
Huang X, Guo J, Fang W, Man Y, Xi J and Li J: MiR-301a mediates the
effect of IL-6 on the AKT/GSK pathway and hepatic glycogenesis by
regulating PTEN expression. Cell Physiol Biochem. 35:1413–1424.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dou L, Zhao T, Wang L, Huang X, Jiao J,
Gao D, Zhang H, Shen T, Man Y, Wang S and Li J: miR-200s contribute
to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes.
J Biol Chem. 288:22596–22606. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang S, Li X and Zhu H: MicroRNA-152
targets phosphatase and tensin homolog to inhibit apoptosis and
promote cell migration of nasopharyngeal carcinoma cells. Med Sci
Monit. 22:4330–4337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou J, Zhang Y, Qi Y, Yu D, Shao Q and
Liang J: MicroRNA-152 inhibits tumor cell growth by directly
targeting RTKN in hepatocellular carcinoma. Oncol Rep.
37:1227–1234. 2017. View Article : Google Scholar : PubMed/NCBI
|
